Report error Found 273 Enz. Inhib. hit(s) with Target = 'Hepatocyte nuclear factor 4-alpha'
Affinity DataEC50: 6nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 13nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 14nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataKd: 23nMAssay Description:Binding affinity to lipid free human HNFalpha (147 to 377) assessed as dissociation constant by isothermal titration calorimetry (ITC) analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 30nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 30nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 40nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 41nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 50nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 60nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 60nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 130nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 140nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 150nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 250nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 300nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataIC50: 320nMAssay Description:Inverse agonist at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured aft...More data for this Ligand-Target Pair
Affinity DataEC50: 330nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataKd: 360nMAssay Description:Binding affinity to human HNFalpha orthosteric ligand binding site (147 to 377) assessed as dissociation constant in presence of fatty acid by isothe...More data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inverse agonist at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured aft...More data for this Ligand-Target Pair
Affinity DataEC50: 1.20E+3nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 1.22E+3nMAssay Description:Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase ...More data for this Ligand-Target Pair
Affinity DataEC50: 1.28E+3nMAssay Description:Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase ...More data for this Ligand-Target Pair
Affinity DataEC50: 1.30E+3nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair
Affinity DataEC50: 1.47E+3nMAssay Description:Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase ...More data for this Ligand-Target Pair
Affinity DataEC50: 1.80E+3nMAssay Description:Agonist activity at human Gal4-HNFalpha-LBD expressed in HEK293T cells transfected with pFR-Luc/pRLSV40 assessed as relative luminescence measured af...More data for this Ligand-Target Pair















































